I'm not accepting it as set in stone since we haven't seen trial protocols, but, it's all I have to go on at the current time.
And, I don't find it odd since the company is likely trying to cut trial costs. If so, it makes sense to have the majority tested in Russia.
Message in reply to:
I’m waiting for information form Leo. I wouldn’t assume only 14 patients in the u.s. because of what the Russia website says. I was asking because you appeared to accept that that’s a fact and I wondered why.